| Name | 2,2'-((5-Carboxy-4-(carboxymethyl)-3-cyanothiophen-2-yl)azanediyl)diacetic acid, distrontium salt |
|---|---|
| Synonyms |
TrontiuMranelate
2,2'-((5-Cboxy-4-(cboxymethyL Strontium ranelate an antiosteoporotic agent Ranelate StrontiuM StrontiuM Ranelic Ranelic Acid Strontium Salt Protos Strontium ranelate in stock Factory StrontiuM ranelate (Protelos) Ranelic acid strontium salt 2-[N,N-Di(cboxymethyl)amino]-3-cyano-4-cboxymethylthiophene-5-cboxylic acid strontium salt 2,2'-((5-Cboxy-4-(cboxymethyl)-3-cyanothiophen-2-yl)azanediyl)diacetic acid, distrontium salt Fenoxaprop-P 113-0 3-(3-Cyano-4-cboxymethyl-5-cboxy-2-thienyl)-3-azapentanedioic distrontium salt StronitiuM ranelate distrontium renelate StrontiuM 2,2'-((5-cboxylato-4-(cboxylatoMethyl)-3-cyanothiophen-2-yl)azanediyl)diacetate )diacetic acid, distrontium saL 5-[Bis(carboxymethyl)amino]-3-(carboxymethyl)-4-cyano-2-thiophenecarboxylic acid Strontium ranelate ISO 9001:2015 REACH StrontiuM ranelate SynonyMs DistrontiuM renelate S 12 2,2'-((5-Cboxy-4-(cboxymethyl)-3-cyanothiophen-2-yl)azanediyl)diaceticacid,distrontiumsal Ranelic acid distrontium salt Srtontiumranelate STRONTIUM RANELATE 5-[Bis(carboxymethyl)amino]-3-(carboxymethyl)-4-cyanothiophene-2-carboxylic acid Strontium Ranelate (S12911 5-[bis(cboxymethyl)amino]-2-cboxy-4-cyano-3-thiopheneacetic acid strontium salt (1:2) 3-Thiopheneacetic acid, 5-(bis(cboxymethyl)amino)-2-cboxy-4-cyano-, strontium salt (1:2) Protelos )-3-cyanothiophen-2-yL 5-[Bis(cboxymethyl)amino]-2-cboxy-4-cyano-3-thiopheneacetic Acid Strontium Salt Strontium ranelate, 10 mM in DMSO 2,2'-((5-Cboxy-4-(cboxymethyl)-3-cyanothiophen-2-yl)azanediyl)diacetic acid, distrontium s Strontium Ranelate.H2O Strontium ranelate htahydrate |
| Description | Strontium ranelate(S12911) stimulates the calcium sensing receptors (CaSR) and leads to the differentiation of pre-osteoblast to osteoblast which increases the bone formation.IC50 value:Target: CaSRStrontium Ranelate is a bone metabolism modulator that inhibits bone resorption while maintaining bone formation. Strontium Ranelate acts by increasing bone formation and decreasing bone resorption, thus rebalancing bone turnover in favour of bone formation, an effect that results in increased bone mass and strength. Commonly used as an antiosteoporotic. Strontium Ranelate has shown efficacy in preventing early postmenopausal bone loss and reducing the risk of hip fracture in women with postmenopausal osteoporosis. |
|---|---|
| Related Catalog | |
| References |
[4]. Sorbera, L.A., Castaner, et al . Strontium Ranelate .Drugs Fut 2003, 28(4): 328 |
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 778.8±60.0 °C at 760 mmHg |
| Melting Point | >310°C (dec.) |
| Molecular Formula | C12H6N2O8SSr2 |
| Molecular Weight | 513.49 |
| Flash Point | 424.8±32.9 °C |
| PSA | 160.47000 |
| LogP | -0.90 |
| Vapour Pressure | 0.0±2.8 mmHg at 25°C |
| Index of Refraction | 1.695 |
| Storage condition | -20°C Freezer |
| Water Solubility | H2O: soluble1mg/mL, clear (warmed) |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 + H312 + H332 |
| Precautionary Statements | P280 |
| Hazard Codes | Xn |
| Risk Phrases | 20/21/22 |
| Safety Phrases | 36/37 |
| RIDADR | 3077 |
| RTECS | XM7581000 |
| HS Code | 2942000000 |
| HS Code | 2942000000 |
|---|